EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Predictive Value of Circulating Renalase for Left Ventricular Hypertrophy in Non-Dialysis CKD Patients

Karrar Mohammed Abbas, Mohammed Mahmmod Mohammed, Mohammed Abdel Alhassan Hamas

Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) · 01.05.2026 · 10 (2) · 192-201

DOI: 10.54133/ajms.v10i2.2721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), online erschienen am 01.05.2026. Verfasst von Karrar Mohammed Abbas und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) is a global health burden strongly associated with cardiovascular morbidity and mortality. Left ventricular hypertrophy (LVH), a hallmark of cardiac remodeling in CKD, is a major predictor of heart failure and sudden cardiac death. Current biomarkers fail to capture early remodeling risk adequately, underscoring the need for novel predictors.

Objective

To evaluate serum renalase levels in non-dialysis CKD patients (stages 3–5) and determine its predictive value for cardiac remodeling, particularly LVH.

Methods

A cross-sectional study was conducted, including 89 CKD patients, 40 heart failure patients, and 37 healthy controls. Demographic, clinical, biochemical, and echocardiographic data were collected. Serum renalase was measured using ELISA. Logistic regression models and receiver operating characteristic (ROC) analyses were applied to assess the independent predictive value of renalase for cardiac remodeling.

Results

CKD patients with cardiac remodeling had significantly higher renalase levels compared to those without (36.31ng/mL vs. 33.05ng/mL, p=0.009). ROC analysis yielded an AUC of 0.656, with a cutoff value of >37.64 ng/mL (sensitivity, 47.5%; specificity, 83.3%). Logistic regression confirmed renalase as an independent predictor of remodeling (adjusted OR: 1.105, 95% CI=1.036–1.178, p=0.002), alongside uncontrolled hypertension (OR=3.462, p=0.014).

Conclusions

Serum renalase is independently associated with LVH in non-dialysis CKD patients and demonstrates moderate discriminative ability with high specificity. These findings highlight renalase as a promising biomarker for early cardiac risk stratification in CKD, warranting further longitudinal validation and standardization of measurement protocols.

Zitieren

APA

Abbas, K. M., Mohammed, M. M., & Hamas, M. A. A. (2026). Predictive Value of Circulating Renalase for Left Ventricular Hypertrophy in Non-Dialysis CKD Patients. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 10(2), 192-201. https://doi.org/10.54133/ajms.v10i2.2721

Vancouver

Abbas KM, Mohammed MM, Hamas MAA. Predictive Value of Circulating Renalase for Left Ventricular Hypertrophy in Non-Dialysis CKD Patients. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 2026;10(2):192-201. doi:10.54133/ajms.v10i2.2721

BibTeX
@article{Abbas2026,
  author = {Abbas, Karrar Mohammed and Mohammed, Mohammed Mahmmod and Hamas, Mohammed Abdel Alhassan},
  title = {Predictive Value of Circulating Renalase for Left Ventricular Hypertrophy in Non-Dialysis CKD Patients},
  journal = {Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )},
  year = {2026},
  volume = {10},
  number = {2},
  pages = {192--201},
  doi = {10.54133/ajms.v10i2.2721}
}
Kostenlos starten →